11.06.2021 Views

Antacids Market Growth Prospect, End-User Analysis and Future Projections till 2025

The scope of the global Antacids Market was appreciated at US$ 5.83 billion in 2017. The range is projected to touch US$ 7.91 billion by 2025, growing at a CAGR of 3.9% for the duration of the forecast. This could be due to increase in geriatric population encountering GERD (Gastroesophageal reflux disease), poor eating habits causing acidity, and the ill-effects of anti-inflammatory, non-steroidal drugs.

The scope of the global Antacids Market was appreciated at US$ 5.83 billion in 2017. The range is projected to touch US$ 7.91 billion by 2025, growing at a CAGR of 3.9% for the duration of the forecast. This could be due to increase in geriatric population encountering GERD (Gastroesophageal reflux disease), poor eating habits causing acidity, and the ill-effects of anti-inflammatory, non-steroidal drugs.

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Antacids Market Growth Prospect, End-User

Analysis and Future Projections till 2025

“The range is projected to touch US$ 7.91 billion by 2025, growing at a CAGR of 3.9% for the duration of the

forecast. This could be due to increase in geriatric population encountering GERD (Gastroesophageal reflux

disease), poor eating habits causing acidity, and the ill-effects of anti-inflammatory, non-steroidal drugs.”

The scope of the global Antacids Market was appreciated at US$ 5.83 billion in 2017. The range is projected to touch

US$ 7.91 billion by 2025, growing at a CAGR of 3.9% for the duration of the forecast. This could be due to increase in

geriatric population encountering GERD (Gastroesophageal reflux disease), poor eating habits causing acidity, and

the ill-effects of anti-inflammatory, non-steroidal drugs.

It’s a known fact that amongst the elderly populace, there is a recurrence of acidic complications. This comes across

as a challenge for gastroenterologist as well as the primary care provider. Plus, these patients do suffer from disorders

like erosive esophagitis, esophageal cancer, and Barrett esophagus. The treatment herein needs an amalgamation of

therapies. This is where antacids come into picture.

Browse Full Research Report @

https://www.millioninsights.com/industry-reports/antacids-market

Besides, growth in e-Commerce is expected to drive demand for antacids via online retailing channels in the

subsequent years. In other words, growing popularity on the part of e-Commerce coupled with increase in online

medicine providers is expected to bolster the market. At the same time, restraints do exist in the form of intake by

young children. “Gut” journal states that young children displayed obesity symptoms on intake of antacids. As far as

infants are concerned, antacids are a strict “no-no”. Even during pregnancy antacids should be avoided as chances of

pre-mature birth can’t be ruled out.

The antacids market is segmented on the basis of drug class, type of formulation, distribution channel, and

geography. By drug class, the segmentation spans proton pump inhibitors, H2 antagonist (interventional/surgical

simulators), and acid neutralizers. By type of formulation, the antacids industry comprises tablet, liquid, and powder.

By distribution channel, it consists of retail pharmacies, hospital pharmacies, and the other distribution channels. By

geography, the antacid market is segmented into North America, LATAM, Asia Pacific, Europe, and MEA.


The players contributing to the antacids market include Bayer AG, AstraZeneca PLC, Sanofi S.A., Reckitt Benckiser

Group PLC, Procter & Gamble, Pfizer Inc., Johnson & Johnson, and Dr. Reddy’s Laboratories Ltd.

Request Sample Copy of This Report @

https://www.millioninsights.com/industry-reports/antacids-market/request-sample

Market Segment:

Antacid Dosage Form Outlook (Revenue, USD Million, 2014 - 2025)

• Tablet

• Liquid

• Others

Antacid Distribution Channel Outlook (Revenue, USD Million, 2014 - 2025)

• Hospital Pharmacy

• Retail Pharmacy

• Online Pharmacy

Antacid Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America

• U.S.

• Canada

• Europe

• U.K.

• Germany

• Asia Pacific

• Japan

• China


• India

• Latin America

• Brazil

• Mexico

• Middle East & Africa

• South Africa

See More Reports of This Category by Million Insights @

https://www.millioninsights.com/industry/pharmaceuticals

Get in touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction.

Our representatives strive to understand diverse client requirements and cater to the same with

the most innovative and functional solutions.

Contact Person:

Ryan Manuel

Research Support Specialist, USA

Email: ryan@millioninsights.com

Global Headquarters

Million Insights

Felton Office Plaza 6265 Highway 9

Felton, California 95018, United States

Phone: 1-408-610-2300

Email: sales@millioninsights.com

Asia Pacific

Million Insights

Office No. 302, 3rd Floor, Manikchand

Galleria, Model Colony, Shivaji Nagar,

Pune, MH, 411016 India

Phone: 91-20-65300184

Email: sales@millioninsights.com

Visit Our Blog: www.millioninsights.blogspot.com

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!